Esophagus to Small Intestine

Clin Gastroenterol Hepatol. 2022;20(12):2753–62.e2

Schuitenmaker JM, Kuipers T, Oude Nijhuis RAB, Schijven MP, Smout AJPM, Fockens P, Bredenoord AJ

Sleep positional therapy for nocturnal gastroesophageal reflux: A double-blind, randomized, sham-controlled trial


Background and aims: Experimental studies have suggested that sleep position plays a role in the occurrence of nocturnal gastroesophageal reflux and the left lateral decubitus position is most favorable. The aim of this study was to evaluate the effect of a novel electronic sleep positional therapy wearable device on sleep position and nocturnal reflux symptoms.
Methods: The authors performed a double-blind, randomized, sham-controlled trial in patients with nocturnal symptoms of gastroesophageal reflux. Patients were advised to sleep in the left lateral decubitus position and were assigned randomly (1:1) to an electronic sleep positional therapy wearable device, programmed to either produce a vibration when in the right lateral position (intervention) or only during the first 20 minutes (sham). The primary outcome was treatment success, defined as a 50% or more reduction in the nocturnal reflux score. Secondary outcomes included change in sleep position and reflux symptoms.
Results: 100 patients were randomized. In the intention-to-treat analysis, the rate of treatment success was 44% in the intervention group (22/50) versus 24% in the sham group (12/50) (risk difference, 20%; 95% confidence interval [CI]: 1.8–38.2%; p = 0.03). Treatment led to a significant avoidance of sleeping in the right lateral decubitus position (intervention 2.2% vs. sham 23.5%; p = 0.000) and increased time sleeping in the left lateral decubitus position (intervention 60.9% vs. sham 38.5%; p = 0.000). More reflux-free nights were observed in the intervention group (intervention 9 [interquartile range {IQR}, 6–11] nights vs. sham 6 [IQR, 3–9] nights; p = 0.01).

Conclusions: Sleep positional therapy using an electronic wearable device promotes sleeping in the left lateral decubitus position and effectively alleviates nocturnal reflux symptoms compared with sham treatment.

Dr. J.M. Schuitenmaker, Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Location AMC, Amsterdam, The Netherlands,
E-Mail: j.m.schuitenmaker@amsterdamumc.nl

DOI: 10.1016/j.cgh.2022.02.058

Back to overview

this could be of interest:

Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge

Gastroenterology. 2022;163(6):1510–21.e6

Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomized controlled trial

Lancet Gastroenterol Hepatol. 2022;7(12):1103–11

More articles on the topic